Patents Assigned to Ascribe Bioscience Inc.
  • Patent number: 12454543
    Abstract: This application relates to efficient methods for the synthesis of ascarylose and its derivatives. A method for the production of ascarylose includes: providing, as a feedstock, a 1-O-substituted rhamnose; forming a mono-sulfonate ester at the 3-OH group of the 1-O-substituted rhamnose; and treating the mono-sulfonate ester with a hydride source to form a 1-O-substituted ascarylose. Forming the mono-sulfonate ester can advantageously be conducted on a 1-O-substituted rhamnose without hydroxyl protecting groups at either the 2-OH or 4-OH-positions.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: October 28, 2025
    Assignee: Ascribe Bioscience Inc.
    Inventor: James Eagan
  • Publication number: 20230279040
    Abstract: This application relates to efficient methods for the synthesis of ascarylose and its derivatives. A method for the production of ascarylose includes: providing, as a feedstock, a 1-O-substituted rhamnose; forming a mono-sulfonate ester at the 3—OH group of the 1-O-substituted rhamnose; and treating the mono-sulfonate ester with a hydride source to form a 1-O-substituted ascarylose. Forming the mono-sulfonate ester can advantageously be conducted on a 1-O-substituted rhamnose without hydroxyl protecting groups at either the 2—OH or 4—OH—positions.
    Type: Application
    Filed: July 30, 2021
    Publication date: September 7, 2023
    Applicant: Ascribe Bioscience Inc.
    Inventor: James Eagan